4-Methoxy-3-(4-methylpiperazin-1-yl)aniline → N-[4-Methoxy-3-(4-methylpiperazin-1-yl)phenyl]-4-(pyridin-4-yl)naphth-1-ylacetamide
반응식
[N:1]1[CH:6]=[CH:5][C:4]([C:7]2[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:10]([CH2:17][C:18](O)=[O:19])=[CH:9][CH:8]=2)=[CH:3][CH:2]=1.[CH3:21][O:22][C:23]1[CH:29]=[CH:28][C:26]([NH2:27])=[CH:25][C:24]=1[N:30]1[CH2:35][CH2:34][N:33]([CH3:36])[CH2:32][CH2:31]1>>[CH3:21][O:22][C:23]1[CH:29]=[CH:28][C:26]([NH:27][C:18](=[O:19])[CH2:17][C:10]2[C:11]3[C:16](=[CH:15][CH:14]=[CH:13][CH:12]=3)[C:7]([C:4]3[CH:3]=[CH:2][N:1]=[CH:6][CH:5]=3)=[CH:8][CH:9]=2)=[CH:25][C:24]=1[N:30]1[CH2:31][CH2:32][N:33]([CH3:36])[CH2:34][CH2:35]1참가 물질
3
실험 절차
The title compound was prepared from 4-(pyridin-4-yl)naphth-1-ylacetic acid (D2) and 4-methoxy-3-(4-methylpiperazin-1-yl)aniline (EP0533268A1) following a similar procedure to Example 1.
출처 및 근거
- ORD 기록
- ord-5840d63c09c74ad48e8caad4613f2e3c
- 출처 데이터셋
- uspto-grants-2000_12
- 특허 번호